what we do
Ageing Research at King’s (ARK) has developed Europe’s first Longevity AI Consortium in 2019, building upon the foundation it has already established ageing and longevity research to turn scientific innovations into clinical realities. King’s College London is an ideal location for the first Longevity AI Consortium in the UK because it has dedicated divisions and resources both for AI and for Longevity. Furthermore, being located in London, it is in an ideal physical location to engage in cross-sector and industry-academic collaboration.
The Longevity AI Consortium will serve as a leading R&D hub and industry-academic hotspot for advanced AI-driven AI-driven personalized preventive diagnostics, prognostics and therapeutics. The main concept of precision medicine is providing health care which is individually tailored on the basis of a person’s genes, lifestyle and environment. With the advances in genetics, artificial intelligence and the growing availability of health data, present an opportunity to make precise personalized patient care a clinical reality.